Immungenetics AG

1 clinical trials · Sponsor

Record	Firm	Date
Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers (NCT03417986)	Immungenetics AG	2017-11-24

Every clearance here is in the API, with alerts when new ones post.